Refine by
Respiratory Triplex Panel Equipment & Supplies
18 equipment items found
Manufactured by:HymonBio Co.,Ltd based inSuzhou, CHINA
Hymon Respiratory Triplex Panel Test Kit applies innovative “one-step method” to solve the cumbersome problem of nucleic acid extraction for SARS-CoV-2, influenza A and influenza B viruses; The nucleic acid is automatically released in 3 minutes, with sample-to-results as short as 35 minutes. ...
by:Progentec Diagnostics, Inc. based inOklahoma City, OKLAHOMA (USA)
A TEST TO DETECT RESPIRATORY PATHOGENS. NASAL SWAB ...
Manufactured by:HymonBio Co.,Ltd based inSuzhou, CHINA
Hymon provides a flexible, quantitative PCR respiratory detection solution for quick and sensitive clinical testing, and provide accurate detection results for some of the most common respiratory diseases. Hymon® MULTONETM Respiratory Panel Test Kit adopts multiple qPCR technology and provides a combination panel for simultaneously detecting 12 different ...
Manufactured by:Anatolia Geneworks based inSultanbeyli – Istanbul, TURKEY
Respiratory infections involve bacterial and viral pathogens affecting the upper or lower respiratory tract, and they are one of the major causes of mortality and morbidity, especially among children. Some respiratory infections may only cause mild symptoms such as common cold while some other may result in more serious cases; accounting for around 10 million deaths per year globally. lnvolvement ...
Manufactured by:Roche Diagnostics International AG based inRotkreuz, SWITZERLAND
GenMark’s Respiratory Pathogen Panels identify the most common viral and bacterial organisms associated with upper respiratory infection, including SARS-CoV-2, the virus that causes COVID-19 (on the RP2 ...
Manufactured by:Roche Diagnostics International AG based inRotkreuz, SWITZERLAND
GenMark Diagnostics is committed to meeting customer needs with a broad menu of multiplex molecular products. The products presented in this section are available only in the U.S. at this ...
Manufactured by:FRIZ Biochem GmbH based inNeuried, GERMANY
Differentiate between FLU A/B and relevant respiratory pathogens. res4plex direct RT-PCR is uniquely designed to detect Influenza A,InfluenzaB as well as SARS-CoV-2 and human respiratory syncytial virus (RSV), respectively directly from (an) unprocessed patient sample(s) on a commercial qPCR cycler. ...
Manufactured by:Gold Standard Diagnostics based inDavis, CALIFORNIA (USA)
CE marked, rapid and reliable RT-PCR assay for the differentiation of Omicron from other VOCs (Beta, Gamma, and Delta). GSD NovaType IV SARS-CoV-2 specifically identifies S gene mutations K417N, E484K, and L452R. Screening for S gene mutations K417N and L452R allows for active surveillance of variants Omicron and Delta, ...
Manufactured by:Seegene Inc. based inSongpa-gu, SOUTH KOREA
Comprehensive assay for the detection and identification of 26 pathogens using one-step real-time ...
Manufactured by:Gold Standard Diagnostics based inDavis, CALIFORNIA (USA)
The GSD NovaPrime® TSP SARS-CoV-2 (COVID-19) is intended for the qualitative determination of SARS-CoV-2 genomic RNA in several respiratory sample types to aid in the diagnosis of COVID-19. This product represents an improvement in comparison to its former version GSD NovaPrime® ...
Manufactured by:Gold Standard Diagnostics based inDavis, CALIFORNIA (USA)
The GSD NovaType Detect + Select K417N SARS-CoV-2 is a research use only (RUO) real-time reverse transcription PCR (RT-PCR) assay designed for the simultaneous qualitative detection of SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) genomic RNA and identification of the spike (S) gene mutation K417N. It is intended to aid in the identification of SARS-CoV-2 variant of concern (VOC) ...
Manufactured by:Fusion Genomics Corporation based inBurnaby, BRITISH COLUMBIA (CANADA)
The goal of personalized medicine is to achieve optimal therapy for each patient based on his or her genomic profile. In infectious or host-dependent diseases, this means therapies that also take into account the pathogen’s mutating ...
Manufactured by:OPTI Medical Systems, Inc. based inRoswell, GEORGIA (US) (USA)
OPTI Medical Systems has obtained CE marking for its OPTI SARS-CoV-2/Influenza A/B RT-PCR Test for identification and differentiation of SARS-CoV-2, influenza A, and influenza B RNA. The test is available in countries accepting the CE mark. This respiratory panel distinguishes between SARS-CoV-2 and influenza A and B extracted from nasopharyngeal swabs. Use of this test is ideal for identifying ...
Manufactured by:Gold Standard Diagnostics based inDavis, CALIFORNIA (USA)
The Mplex Monkeypox, Orthopox is a research use only (RUO) Real-time PCR assay designed for the simultaneous qualitative detection of the monkeypox virus and its differentiation from other orthopox viruses. Sample material should be DNA extracted from human upper respiratory specimen types, whole blood, serum or pustule specimen types. ...
Manufactured by:Mikrogen GmbH based inNeuried, GERMANY
Real-time Multiplex RT-PCR test for the detection of Bordetella pertussis, Bordetella parapertussis, Bordetella holmesii. ...
Manufactured by:Bio Fire Diagnostics based inSalt Lake City, UTAH (USA)
The BioFire RP EZ uses a molecular syndromic approach to accurately detect and identify a wide range of pathogens—not just Flu A and Flu B. As a healthcare provider, this means your patients can receive the right treatment the first time, potentially leading to higher patient satisfaction and lower costs. And as the name implies, it’s easy and can be performed right in your office or ...
Manufactured by:Bio Fire Diagnostics based inSalt Lake City, UTAH (USA)
SARS-CoV-2 is a top concern for patients and clinicians, but several respiratory pathogens can cause nearly indistinguishable symptoms. The FDA De Novo authorized BioFire RP2.1 Panel is a frontline test to help clinicians quickly diagnose respiratory infections, including COVID-19, influenza, RSV, and many ...
Manufactured by:Gold Standard Diagnostics based inDavis, CALIFORNIA (USA)
Respiratory diseases caused by SARS-CoV-2, RSV, and Influenza virus have similar first clinical symptoms, and accurate identification is crucial for better patient care. Gold Standard Diagnostics’ new multiplex assays have been specifically designed to detect and differentiate these viral infections in the same PCR run. The Mplex SARS-CoV-2+, Flu A, Flu B (C1) RT-PCR assay allows to ...